• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Changes in blood vessel maturation in the fibrous cap of the tumor rim.肿瘤边缘纤维帽中血管成熟度的变化。
Cancer Sci. 2012 Mar;103(3):433-8. doi: 10.1111/j.1349-7006.2011.02157.x. Epub 2011 Dec 21.
2
Endothelial cells expressing Bcl-2 promotes tumor metastasis by enhancing tumor angiogenesis, blood vessel leakiness and tumor invasion.表达Bcl-2的内皮细胞通过增强肿瘤血管生成、血管渗漏和肿瘤侵袭来促进肿瘤转移。
Lab Invest. 2008 Jul;88(7):740-9. doi: 10.1038/labinvest.2008.46. Epub 2008 May 19.
3
Tumor vessel development and maturation impose limits on the effectiveness of anti-vascular therapy.肿瘤血管的发育和成熟限制了抗血管治疗的有效性。
Am J Pathol. 2003 Jan;162(1):183-93. doi: 10.1016/S0002-9440(10)63809-6.
4
2-Methoxycinnamaldehyde inhibits tumor angiogenesis by suppressing Tie2 activation.2-甲氧基肉桂醛通过抑制 Tie2 激活抑制肿瘤血管生成。
Biochem Biophys Res Commun. 2011 Nov 11;415(1):174-80. doi: 10.1016/j.bbrc.2011.10.053. Epub 2011 Oct 18.
5
Altered angiogenesis in the tumor microenvironment.肿瘤微环境中的血管生成改变。
Pathol Int. 2011 Nov;61(11):630-7. doi: 10.1111/j.1440-1827.2011.02726.x. Epub 2011 Oct 10.
6
Evaluation of hypericin-mediated photodynamic therapy in combination with angiogenesis inhibitor bevacizumab using in vivo fluorescence confocal endomicroscopy.采用体内荧光共聚焦内镜评价金丝桃素介导的光动力疗法联合抗血管生成抑制剂贝伐单抗的效果。
J Biomed Opt. 2010 Jan-Feb;15(1):011114. doi: 10.1117/1.3281671.
7
[Immune therapy and tumor angiogenesis].[免疫疗法与肿瘤血管生成]
Rinsho Ketsueki. 2020;61(9):1440-1445. doi: 10.11406/rinketsu.61.1440.
8
Effects of the tumor-vasculature-disrupting agent verubulin and two heteroaryl analogues on cancer cells, endothelial cells, and blood vessels.肿瘤血管破坏剂长春瑞滨及其两种杂芳基类似物对癌细胞、内皮细胞和血管的作用。
ChemMedChem. 2014 Apr;9(4):847-54. doi: 10.1002/cmdc.201300531. Epub 2014 Feb 23.
9
Tumor angiogenesis and accessibility: role of vascular endothelial growth factor.肿瘤血管生成与可及性:血管内皮生长因子的作用
Semin Oncol. 2002 Dec;29(6 Suppl 16):3-9. doi: 10.1053/sonc.2002.37265.
10
Vascular disrupting agents in cancer therapy.血管破坏剂在癌症治疗中的应用。
Eur J Pharmacol. 2021 Jan 15;891:173692. doi: 10.1016/j.ejphar.2020.173692. Epub 2020 Oct 29.

引用本文的文献

1
Autophagy, a double-edged sword in anti-angiogenesis therapy.自噬,抗血管生成治疗中的一把双刃剑。
Med Oncol. 2016 Jan;33(1):10. doi: 10.1007/s12032-015-0721-9. Epub 2015 Dec 29.
2
Evaluation of PSF1 as a prognostic biomarker for prostate cancer.评估PSF1作为前列腺癌预后生物标志物的价值。
Prostate Cancer Prostatic Dis. 2015 Mar;18(1):56-62. doi: 10.1038/pcan.2014.46. Epub 2014 Nov 18.
3
Natriuretic peptide receptor A signaling regulates stem cell recruitment and angiogenesis: a model to study linkage between inflammation and tumorigenesis.利钠肽受体 A 信号转导调节干细胞募集和血管生成:研究炎症与肿瘤发生之间联系的模型。
Stem Cells. 2013 Jul;31(7):1321-9. doi: 10.1002/stem.1376.

本文引用的文献

1
The apelin/APJ system induces maturation of the tumor vasculature and improves the efficiency of immune therapy.Apelin/APJ 系统可诱导肿瘤血管成熟,提高免疫治疗的效率。
Oncogene. 2012 Jul 5;31(27):3254-64. doi: 10.1038/onc.2011.489. Epub 2011 Oct 31.
2
Persistent vascular normalization as an alternative goal of anti-angiogenic cancer therapy.抗血管生成癌症治疗的另一个目标:持续的血管正常化。
Cancer Sci. 2011 Jul;102(7):1253-6. doi: 10.1111/j.1349-7006.2011.01929.x. Epub 2011 Apr 14.
3
Anti-VEGF treatment reduces blood supply and increases tumor cell invasion in glioblastoma.抗血管内皮生长因子治疗减少胶质母细胞瘤的血液供应并增加肿瘤细胞浸润。
Proc Natl Acad Sci U S A. 2011 Mar 1;108(9):3749-54. doi: 10.1073/pnas.1014480108. Epub 2011 Feb 14.
4
Bone marrow-derived myofibroblasts contribute to the mesenchymal stem cell niche and promote tumor growth.骨髓衍生的肌成纤维细胞有助于间充质干细胞生态位并促进肿瘤生长。
Cancer Cell. 2011 Feb 15;19(2):257-72. doi: 10.1016/j.ccr.2011.01.020.
5
PSF1, a DNA replication factor expressed widely in stem and progenitor cells, drives tumorigenic and metastatic properties.PSF1,一种在干细胞和祖细胞中广泛表达的 DNA 复制因子,驱动致瘤和转移特性。
Cancer Res. 2010 Feb 1;70(3):1215-24. doi: 10.1158/0008-5472.CAN-09-3662. Epub 2010 Jan 26.
6
Collective cell migration in morphogenesis, regeneration and cancer.形态发生、再生和癌症中的集体细胞迁移。
Nat Rev Mol Cell Biol. 2009 Jul;10(7):445-57. doi: 10.1038/nrm2720.
7
Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis.用强效肿瘤血管生成抑制剂进行短期治疗后转移加速。
Cancer Cell. 2009 Mar 3;15(3):232-9. doi: 10.1016/j.ccr.2009.01.021.
8
Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis.抗血管生成疗法会引发肿瘤的恶性进展,导致局部侵袭增加和远处转移。
Cancer Cell. 2009 Mar 3;15(3):220-31. doi: 10.1016/j.ccr.2009.01.027.
9
VEGF inhibition: insights from preclinical and clinical studies.血管内皮生长因子抑制:临床前和临床研究的见解
Cell Tissue Res. 2009 Jan;335(1):261-9. doi: 10.1007/s00441-008-0675-8. Epub 2008 Sep 3.
10
VEGF-targeted therapy: mechanisms of anti-tumour activity.血管内皮生长因子靶向治疗:抗肿瘤活性机制
Nat Rev Cancer. 2008 Aug;8(8):579-91. doi: 10.1038/nrc2403. Epub 2008 Jul 3.

肿瘤边缘纤维帽中血管成熟度的变化。

Changes in blood vessel maturation in the fibrous cap of the tumor rim.

机构信息

Department of Signal Transduction, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan.

出版信息

Cancer Sci. 2012 Mar;103(3):433-8. doi: 10.1111/j.1349-7006.2011.02157.x. Epub 2011 Dec 21.

DOI:10.1111/j.1349-7006.2011.02157.x
PMID:22098620
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7713628/
Abstract

It is widely accepted that blood vessels in the tumor microenvironment are immature because mural cell (MC) adhesion to endothelial cells (ECs) is broadly lacking. Hyperpermeability of the tumor vasculature then results in interstitial hypertension that mitigates against penetration of anticancer drugs into the depths of the tumor. It has been suggested that treatment with angiogenesis inhibitors normalizes blood vessels, resulting in restoration of normal permeability and improved drug delivery. However, recent reports suggest that cancer cell invasion is induced from the edge of the tumor into peripheral areas after treatment with angiogenesis inhibitors. Therefore, it is important to assess the status of blood vessels in the fibrous cap at the tumor rim after antiangiogenesis therapy. In the present study, we found that mature blood vessels in which ECs are covered with MCs are present in the fibrous cap. After treatment with angiogenesis inhibitors, immature blood vessels were destroyed and vascular function was significantly improved, but maturing blood vessels in which ECs were covered with MCs remained visible. These maturing blood vessels showed a less dilated character after treatment with the angiogenesis inhibitors. It is widely accepted that well-matured blood vessels are sheathed in extracellular matrix (ECM) and that cancer cells migrate along tracks made of ECM collagen fibers. Therefore, our data indicate the importance of destroying maturing blood vessels outside the tumor parenchyma to prevent cancer cell invasion.

摘要

人们普遍认为肿瘤微环境中的血管不成熟,因为壁细胞(MC)与内皮细胞(EC)的黏附广泛缺失。肿瘤血管的高通透性导致间质高血压,从而阻碍抗癌药物渗透到肿瘤深部。有人提出,用血管生成抑制剂治疗可使血管正常化,从而恢复正常的通透性并改善药物输送。然而,最近的报告表明,在用血管生成抑制剂治疗后,癌细胞会从肿瘤边缘侵入周围区域。因此,评估抗血管生成治疗后肿瘤边缘纤维帽中血管的状态非常重要。在本研究中,我们发现成熟的血管中 EC 被 MC 覆盖,存在于纤维帽中。在用血管生成抑制剂治疗后,不成熟的血管被破坏,血管功能显著改善,但被 MC 覆盖的 EC 成熟血管仍然可见。这些成熟的血管在用血管生成抑制剂治疗后表现出较少的扩张特征。人们普遍认为,成熟良好的血管被细胞外基质(ECM)包裹,癌细胞沿着 ECM 胶原纤维制成的轨道迁移。因此,我们的数据表明,破坏肿瘤实质外成熟的血管对于防止癌细胞侵袭非常重要。